CCNH
Cyclin-H
Also known as: CCNH_HUMAN, CycH, p34, p37
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P51946
- Gene
- CCNH
- Ensembl
- ENSG00000134480
- Chromosome
- 5
- Canonical length
- 323 aa
- Protein class
- Cancer-related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with CDK7 kinase and ring finger protein MAT1. The kinase complex is able to phosphorylate CDK2 and CDC2 kinases, thus functions as a CDK-activating kinase (CAK). This cyclin and its kinase partner are components of TFIIH, as well as RNA polymerase II protein complexes. They participate in two different transcriptional regulation processes, suggesting an important link between basal transcription control and the cell cycle machinery. A pseudogene of this gene is found on chromosome 4. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Nov 2010]
Canonical amino-acid sequenceUniProt
323 residues, UniProt reviewed canonical sequence.
>P51946|CCNH
1 MYHNSSQKRH WTFSSEEQLA RLRADANRKF RCKAVANGKV LPNDPVFLEP HEEMTLCKYY
61 EKRLLEFCSV FKPAMPRSVV GTACMYFKRF YLNNSVMEYH PRIIMLTCAF LACKVDEFNV
121 SSPQFVGNLR ESPLGQEKAL EQILEYELLL IQQLNFHLIV HNPYRPFEGF LIDLKTRYPI
181 LENPEILRKT ADDFLNRIAL TDAYLLYTPS QIALTAILSS ASRAGITMES YLSESLMLKE
241 NRTCLSQLLD IMKSMRNLVK KYEPPRSEEV AVLKQKLERC HSAELALNVI TKKRKGYEDD
301 DYVSKKSKHE EEEWTDDDLV ESLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CCNH can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 51 nTPM
Expression across tissuesHPA
Tissue
- testis: 51 nTPM
- adipose tissue: 37 nTPM
- bone marrow: 36 nTPM
- liver: 35 nTPM
- thymus: 34 nTPM
- breast: 29 nTPM
Single-cell type
- neutrophils: 1,359 nCPM
- vascular smooth muscle cells: 887 nCPM
- innate lymphoid cells: 848 nCPM
- t-cells: 769 nCPM
- mast cells: 761 nCPM
- adipocytes: 656 nCPM
Immune cell
- eosinophil: 59 nTPM
- non-classical monocyte: 50 nTPM
- basophil: 50 nTPM
- intermediate monocyte: 47 nTPM
- T-reg: 45 nTPM
- myeloid DC: 45 nTPM
Brain region
- cerebellum: 34 nTPM
- cerebral cortex: 25 nTPM
- white matter: 24 nTPM
- hypothalamus: 21 nTPM
- hippocampal formation: 20 nTPM
- medulla oblongata: 19 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.81
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.1
- DepMap mean gene effect
- -1.24
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- protein stabilization
- regulation of G1/S transition of mitotic cell cycle
- regulation of transcription by RNA polymerase II
- transcription initiation at RNA polymerase II promoter
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CCNH in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CCNH as an antibody target. Whether an autoantibody or antibody against CCNH could matter depends on whether native CCNH is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CCNH is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CCNH as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...